AR002385A1 - Metodo para preparar ureas ciclicas n,n'-disustituidas a partir de diaminodioles lineales. - Google Patents
Metodo para preparar ureas ciclicas n,n'-disustituidas a partir de diaminodioles lineales.Info
- Publication number
- AR002385A1 AR002385A1 ARP960103027A AR10302796A AR002385A1 AR 002385 A1 AR002385 A1 AR 002385A1 AR P960103027 A ARP960103027 A AR P960103027A AR 10302796 A AR10302796 A AR 10302796A AR 002385 A1 AR002385 A1 AR 002385A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- disubstituted
- substituted
- linear
- preparing
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 150000003672 ureas Chemical class 0.000 title 1
- 125000004122 cyclic group Chemical group 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 235000013877 carbamide Nutrition 0.000 abstract 1
- 125000002837 carbocyclic group Chemical group 0.000 abstract 1
- 239000003638 chemical reducing agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000007282 cyclocarbonylation reaction Methods 0.000 abstract 1
- 150000004985 diamines Chemical class 0.000 abstract 1
- -1 disubstituted cyclic ureas Chemical class 0.000 abstract 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 abstract 1
- 125000000524 functional group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 239000004030 hiv protease inhibitor Substances 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 238000005932 reductive alkylation reaction Methods 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/04—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se refiere a un método para preparar ureas cíclicas disustituidas de fórmula (IV). Estos compuestos son útiles como inhibidores dela HIV proteasa para el tratamiento de esa infección HIV. Para la síntesis se parte de diaminoles lineales disustituidos de fórmula (I) que se tratan con unaldehido para obtener una diamina disustituida de fórmula (II) que posteriormente se cicliza (fórmula III) y, finalmente se liberan los H de losOH cíclicos y se eliminan los grupos protectores sustituyentes. En la fórmula IV, R4 y R7 son grupos alquilo C 1-8, alquenilo y alquinilo C 2-8 sustituidos onó y R22 y R23 son de valores similares a R4 y R7 y, además, un anillo carbocíclico C3-14 sustituido e insustituido y un sistema de anilloO0heterocíclico de 5-10 miembros con 1-4 heteroátomos (O, N, S) sustituidos ó no; a: alquilación reductiva con R22 CHO - R23CHO y agente reductor;b: agente de ciclocarbonilación;c: desproteger y convertir grupos funcionales.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/469,409 US5532356A (en) | 1995-06-06 | 1995-06-06 | Method for preparing N,N'-disubstituted cyclic ureas |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR002385A1 true AR002385A1 (es) | 1998-03-11 |
Family
ID=23863677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP960103027A AR002385A1 (es) | 1995-06-06 | 1996-07-06 | Metodo para preparar ureas ciclicas n,n'-disustituidas a partir de diaminodioles lineales. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5532356A (es) |
| EP (1) | EP0830349B1 (es) |
| JP (1) | JPH11506765A (es) |
| AR (1) | AR002385A1 (es) |
| AT (1) | ATE190974T1 (es) |
| AU (1) | AU700805B2 (es) |
| CA (1) | CA2222132A1 (es) |
| DE (1) | DE69607344T2 (es) |
| DK (1) | DK0830349T3 (es) |
| ES (1) | ES2145452T3 (es) |
| GR (1) | GR3033199T3 (es) |
| HR (1) | HRP960258B1 (es) |
| IL (1) | IL122457A0 (es) |
| MX (1) | MX9709125A (es) |
| MY (1) | MY113863A (es) |
| NZ (1) | NZ309557A (es) |
| PT (1) | PT830349E (es) |
| TW (1) | TW355707B (es) |
| WO (1) | WO1996039393A1 (es) |
| ZA (1) | ZA964749B (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5466797A (en) * | 1994-06-30 | 1995-11-14 | The Du Pont Merck Pharmaceutical Company | Intermediates for the preparation of cyclic urea |
| US5532357A (en) * | 1995-06-07 | 1996-07-02 | The Dupont Merck Pharmaceutical Company | Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas |
| US6054597A (en) * | 1995-11-14 | 2000-04-25 | Dupont Pharmaceuticals | Processes and intermediates for the preparation of cyclic urea HIV protease inhibitors |
| JP2001518094A (ja) * | 1997-03-31 | 2001-10-09 | デュポン ファーマシューティカルズ カンパニー | Ｈｉｖプロテアーゼ阻害剤として有用なインダゾール−環式尿素 |
| US6218534B1 (en) * | 1997-10-06 | 2001-04-17 | Dupont Pharmaceuticals Company | Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate |
| US6313110B1 (en) * | 1999-06-02 | 2001-11-06 | Dupont Pharmaceuticals Company | Substituted 2H-1,3-diazapin-2-one useful as an HIV protease inhibitor |
| CA2409009C (en) * | 2000-05-30 | 2006-11-28 | Red Valve Co., Inc. | Method and apparatus for preventing stagnation in fluid reservoirs |
| FR2810039B1 (fr) * | 2000-06-13 | 2007-05-25 | Centre Nat Rech Scient | Composes urees cycliques et leur procede de preparation |
| AU2004303602C1 (en) | 2003-12-23 | 2009-05-28 | Astex Therapeutics Limited | Pyrazole derivatives as protein kinase modulators |
| US8343953B2 (en) * | 2005-06-22 | 2013-01-01 | Astex Therapeutics Limited | Pharmaceutical compounds |
| EP1933832A2 (en) | 2005-06-23 | 2008-06-25 | Astex Therapeutics Limited | Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators |
| US7777030B2 (en) | 2005-12-29 | 2010-08-17 | Centre National de la Recherge Scientifique (CNRS) | Compositions and methods for the treatment and prevention of disease |
| GB0704932D0 (en) | 2007-03-14 | 2007-04-25 | Astex Therapeutics Ltd | Pharmaceutical compounds |
| KR101663255B1 (ko) * | 2015-11-30 | 2016-10-10 | 주식회사 삼양사 | 안정성이 향상된 농축 무수당 알코올 제조용 조성물 및 무수당 알코올의 농축 방법 |
| KR101663264B1 (ko) * | 2015-11-30 | 2016-10-10 | 주식회사 삼양사 | 저장 안정성이 향상된 무수당 알코올 조성물 및 무수당 알코올의 저장 방법 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2131420C1 (ru) * | 1991-10-11 | 1999-06-10 | Дзе Дюпон Мерк Фармасьютикал Компани | Циклические мочевины, способ ингибирования роста ретровирусов и фармацевтическая композиция |
| US5610294A (en) * | 1991-10-11 | 1997-03-11 | The Du Pont Merck Pharmaceutical Company | Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
-
1995
- 1995-06-06 US US08/469,409 patent/US5532356A/en not_active Expired - Fee Related
-
1996
- 1996-06-04 AT AT96917066T patent/ATE190974T1/de not_active IP Right Cessation
- 1996-06-04 AU AU59752/96A patent/AU700805B2/en not_active Ceased
- 1996-06-04 DK DK96917066T patent/DK0830349T3/da active
- 1996-06-04 ES ES96917066T patent/ES2145452T3/es not_active Expired - Lifetime
- 1996-06-04 CA CA002222132A patent/CA2222132A1/en not_active Abandoned
- 1996-06-04 EP EP96917066A patent/EP0830349B1/en not_active Expired - Lifetime
- 1996-06-04 DE DE69607344T patent/DE69607344T2/de not_active Expired - Fee Related
- 1996-06-04 JP JP9501114A patent/JPH11506765A/ja active Pending
- 1996-06-04 IL IL12245796A patent/IL122457A0/xx unknown
- 1996-06-04 MX MX9709125A patent/MX9709125A/es unknown
- 1996-06-04 NZ NZ309557A patent/NZ309557A/en unknown
- 1996-06-04 WO PCT/US1996/008556 patent/WO1996039393A1/en active IP Right Grant
- 1996-06-04 PT PT96917066T patent/PT830349E/pt unknown
- 1996-06-06 HR HR960258A patent/HRP960258B1/xx not_active IP Right Cessation
- 1996-06-06 ZA ZA9604749A patent/ZA964749B/xx unknown
- 1996-06-06 MY MYPI96002264A patent/MY113863A/en unknown
- 1996-07-06 AR ARP960103027A patent/AR002385A1/es unknown
- 1996-07-30 TW TW085109286A patent/TW355707B/zh active
-
2000
- 2000-04-12 GR GR20000400893T patent/GR3033199T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT830349E (pt) | 2000-08-31 |
| GR3033199T3 (en) | 2000-08-31 |
| ATE190974T1 (de) | 2000-04-15 |
| JPH11506765A (ja) | 1999-06-15 |
| US5532356A (en) | 1996-07-02 |
| NZ309557A (en) | 2001-06-29 |
| HRP960258B1 (en) | 2000-12-31 |
| DK0830349T3 (da) | 2000-07-17 |
| HRP960258A2 (en) | 1997-12-31 |
| DE69607344T2 (de) | 2000-09-21 |
| EP0830349A1 (en) | 1998-03-25 |
| AU700805B2 (en) | 1999-01-14 |
| ES2145452T3 (es) | 2000-07-01 |
| WO1996039393A1 (en) | 1996-12-12 |
| EP0830349B1 (en) | 2000-03-22 |
| TW355707B (en) | 1999-04-11 |
| ZA964749B (en) | 1997-12-08 |
| DE69607344D1 (de) | 2000-04-27 |
| CA2222132A1 (en) | 1996-12-12 |
| IL122457A0 (en) | 1998-06-15 |
| MY113863A (en) | 2002-06-29 |
| MX9709125A (es) | 1998-03-31 |
| AU5975296A (en) | 1996-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR002385A1 (es) | Metodo para preparar ureas ciclicas n,n'-disustituidas a partir de diaminodioles lineales. | |
| ES2164920T3 (es) | Nuevos derivados heterociclicos y uso medicinal de los mismos. | |
| AR016762A1 (es) | Compuestos del acido 4-bromo o 4-yodo fenilamino benzohidroxamico, formulaciones farmaceuticas y uso del mismo | |
| DE69522569D1 (de) | Metalloproteinase hemmende verbindungen | |
| CO4920242A1 (es) | Compuestos inhibidores de metalopreoteasas 1,4-heterocicli- cos, composiciones farmaceuticas que los contienen y metodos para su utilizacion | |
| RU95104885A (ru) | 1h-индол-3-глиоксиламиды, ингибирующие spla2-медируемое выделение жирных кислот, фармацевтическая композиция | |
| TR199901055T2 (xx) | Benzimidazol t�revlerinin kristalleri ve bunlar�n �retimi. | |
| ES2151640T3 (es) | Derivados de urea y amida que tienen actividad inhibidora frente al acat, su preparacion y su uso terapeutico y profilactico. | |
| HUP9802859A2 (hu) | Acil-amino-szalicilsav-amid-származékok és alkalmazásuk peszticidként | |
| ES2059327T3 (es) | Derivados de tetrahidronaftaleno y de indano, obtencion de los mismos y utilizacion en preparados farmaceuticos. | |
| EA200200078A1 (ru) | Птеридиноны в качестве ингибиторов киназ | |
| ES2083438T3 (es) | Procedimiento para la preparacion de taxol utilizando una oxazinona. | |
| HUP9701048A2 (hu) | Új eljárás sildenafil előállítására és a felhasznált új köztitermékek | |
| PA8504401A1 (es) | Compuestos farmaceuticamente activos | |
| AR004961A1 (es) | Modificacion cristalina v del clorhidrato de(r)-(-)-2-{n-[4-(1,1-dioxido-3- oxo-2,3-dihidro-benzisotiazol-2-il)-butil]-aminometil)cromano, unprocedimiento para su preparacion, medicamentos que lo contienen, el uso de dicho clorhidrato para la preparacion de medicamentos, una composicion para el | |
| TR199900501T2 (xx) | Benzamin t�revleri ve bunlar�n ila� olarak kullan�m�. | |
| CO4900045A1 (es) | Compuestos inhibidores de metaloproteasas espirociclicos, composiciones farmaceuticas que los contienen y metodos para su utilizacion | |
| AR030203A1 (es) | Derivados de carbamato de 2-(s)-hidroximutilina, composiciones farmaceuticas que los comprenden, procedimiento para prepararlos y 2(s), 11-dihidroxi protegida-mutilina como compuesto intermediario | |
| ES2156120T3 (es) | Derivados arilamidicos. | |
| ES2054626T3 (es) | Derivados de 2-azetidinona sustituidos en las posiciones 3,4 y procedimientos para su preparacion. | |
| PE20040928A1 (es) | Derivados de tetrahidroquinolinas como moduladores del receptor fsh | |
| AR003137A1 (es) | Una composicion farmaceutica para tratar la leucemia | |
| MX169919B (es) | Proceso para la preparacion de derivados de benzotiazol | |
| NO975679L (no) | Fremgangsmåte for fremstilling av N-monosubstituerte og N,N'-disubstituerte, usymmetriske, cykliske ureaer | |
| ES2191341T3 (es) | Derivados de la 2-fenoxianilina. |